Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,852
datasets available to search
ShareScore release 0.7.1
Dataset results
2,852 results for “Hepatocellular carcinoma”
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03434379. IPD Sharing: YES. Countries: 17. Publications: 8.
De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00328770. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01761266. IPD Sharing: Not stated. Countries: 21. Publications: 9.
Multiparametric MRI for Characterization of Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06999174. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
A Study of LY2157299 in Participants With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01246986. IPD Sharing: YES. Countries: 7. Publications: 4.
A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00790218. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy Wi
ClinicalTrials.gov study NCT01140347. IPD Sharing: Not stated. Countries: 27. Publications: 11.
Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)
ClinicalTrials.gov study NCT00692770. IPD Sharing: Not stated. Countries: 28. Publications: 5.
Branched-chain Amino Acid Supplementation for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03908255. IPD Sharing: YES. Countries: 1. Publications: 7.
Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03682276. IPD Sharing: NO. Countries: 1. Publications: 1.
Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01032850. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT04945720. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00492752. IPD Sharing: Not stated. Countries: 3. Publications: 3.
A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03006926. IPD Sharing: NO. Countries: 7. Publications: 1.
Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00287222. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02423343. IPD Sharing: YES. Countries: 2. Publications: 1.
Emulsion Versus Suspension in Chemoembolization for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03268499. IPD Sharing: NO. Countries: 1. Publications: 1.
Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas
ClinicalTrials.gov study NCT00532441. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP)
ClinicalTrials.gov study NCT02329860. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00554372. IPD Sharing: Not stated. Countries: 3. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.